维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Alvanou G"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Are pharmaceuticals potent environmental pollutants? Part I : Environmental risk assessments of selected active pharmaceutical ingredients 显示文摘	CARLSSON C JOHANSSON A K ALVAN G	2006	Science of the Total Environment2006，364，13：	1
2	Hydroxylation polymorphisms of debrisbquine and mephenytoin in European populations 显示文摘	Alvan G Bechtel P Iselius L	1990	Eur J Clin Pharmacol1990，39，6：	1
3	Pharmacokinetics of indomethacin显示文摘	Alvan G Orme M Bertilsson L	1975	Clin Pharmacol Ther1975，18，3：	1
4	Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration显示文摘	Wakelkamp M Alvan G Gabrielsson J	1996	Clin Pharmacol Ther1996，60，1：	1
5	A critical appraisal of the quality of quali- ty-o&life measurements显示文摘	Thomas M G Alvan R F	1994	JAMA1994，272，8：	1
6	Classification of Drugs for Teratogenic Risk显示文摘	Alvan G Lundborg P	1995	Eur J Clin Pharmacol1995，48，：	1
7	Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients 显示文摘	Carlsson C Johansson A Alvan G	2006	Science of the Total Environment2006，364，13：	1
8	Quality and safety considerations for recombinant biological medicines:A regulatory perspective显示文摘	BARNES HJ RAGNARRSON G ALVAN G	2009	Int J Risk Saf Med2009，21，12：	1
9	Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration显示文摘	Wakelkamp M Alvan G Gabrielsson J	1996	Clin Pharrnacol Ther1996，60，1：	1
10	The influence of food intake on the effect of two controlled release formulations of furosemide显示文摘	Paintaud G Alvan G Eckernas SA	1995	Biopharm Drug Dispos1995，16，3：	1
11	Rectal bioavailability of ba campicillin hydrochloride in man as determined by reversed-phase Liquid chromatography显示文摘	Westerlund D Alvan G	1984	Chemotherapy1984，30，：	1
12	Are pharmaceuticals potent environmental pollutants? Part I :Environmental risk assessments of selected active pharmaceutical ingredients 显示文摘	Carlson C Johansson A K Alvan G	2006	Sci Total Environ2006，364，：	1
13	harmacodynamic mode-ling of furosemide tolerance aider mult iple intravenous administration显示文摘	Wakolkamp M Alvan G Gabrielsson J	1996	Clin Pharmacol Ther1996，，：	1
14	Regu- lated and unregulated emissions of a light duty vehicle operated on diesel/palm-based methyl ester blends over NEDC and a non-legislated driving cycle显示文摘	Karavalakis G Alvanou F Stournas S	2009	Fuel2009，88，6：	1
15	Adverse effects of monobactams and carbapenems显示文摘	Alvan G Nord CE	1995	Drug Saf1995，12，5：	1
16	Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine 显示文摘	BRYNNE N DALEN P ALVAN G	1998	Clin Pharmacol Ther1998，63，5：	1
17	Are pharmaceuticals potent environmental pollutants?: Part : Environmental risk assessments of selected active pharmaceutical ingredients显示文摘	Carlsson C Johansson A K Alvan G	2006	Science of the Total Environment2006，364，13：	1
18	Are pharmaceuticals potent environmental pollutants? : Part U : Environmental risk assessments of selected pharmaceutical excipients 显示文摘	Carlsson C Johansson A K Alvan G	2006	Science of the Total Environment2006，364，13：	1
19	The dentinogenic effect of mineral trioxide aggregate (MTA) in short- term capping experiments 显示文摘	Tziafas D Pantelidou A Alvanou G	2002	Int Endo J2002，35，3：	1
20	Pharmacokinetics of indomethacin显示文摘	Alvan G Orme M Bertilsson L	1975	Clin Pharmacol Ther1975，18，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示